Healthcare

Eyecare buys Associated Retinal Consultants

EyeCare Partners, a portfolio company of FFL Partners, has acquired Royal Oak, Michigan-based Associated Retinal Consultants, an ophthalmology provider. No financial terms were disclosed. Metronome Partners LLC served as financial adviser to ARC on the transaction.

Nkarta Therapeutics racks up $114 mln Series B

South San Francisco-based Nkarta Therapeutics, a biopharmaceutical company focused on fighting cancer, has raised $114 million in Series B financing. Samsara BioCapital led the round.

PE HUB Healthcare Wire Highlights, 9.5.19

Back to school: TPG gets into payer services, VPay presses pause

Repare Therapeutics picks up Series B funding

Montreal and Boston-based Repare Therapeutics, a precision oncology company, has closed US$82.5 million in Series B financing. Cowen Healthcare Investments led the round. Other participants in the financing included OrbiMed, Redmile, BVF Partners LP, Logos Capital, Versant Ventures, MPM Capital, Fonds de solidarité FTQ and BDC Capital. In addition to the funding, Kevin Raidy, managing partner at Cowen Healthcare Investments and Dr. David Bonita, a partner at OrbiMed, will join Repare’s board of directors.

Sigrid Therapeutics rakes in $1.6 mln

Stockholm-based Sigrid Therapeutics, which is developing a device to lower blood sugar levels, has raised $1.6 million in funding. Joyance Partners and Pär Gellerfors led the round.

Veralox scores $5.4 mln seed

Frederick, Maryland-based Veralox Therapeutics, a preclinical stage company, has raised $5.4 million in seed funding. JDRF T1D Fund, Sanofi Ventures and the VTC Innovation and VTC Seed Fund led the round with participation from the Maryland Momentum Fund, the University of Vermont Health Network and TEDCO.

Aural Analytics lands $4.3 mln

Aural Analytics Inc, a digital health company focused on building an advanced speech analytics platform, has raised $4.3 million in funding. Morningside Ventures and Tamarisc Ventures led the round.

PathoQuest snags funding

Paris-based PathoQuest, a genomic expert company focused on the microbiology testing market, has raised 8 million euros in funding. The backers include Kurma Partners, Idinvest Partners and Charles River Labs.

iSTAR Medical grabs Series C

Belgium-based iSTAR Medical SA, a developer of ophthalmic implants for the treatment of glaucoma, has raised 40 million euros in Series C financing. LSP and Gimv led the round with participation from Earlybird, BNP Paribas Fortis Private Equity, Capricorn Partners, Walloon Region Investment Fund and Belgian Federal Investment Fund.

Great Hill’s investment in Pareto values it upwards of $200 mln

Pareto Founder and CEO Andrew Cavenagh confirmed that the investment from Great Hill totaled more than $80 million.